![[ICO]](/icons/blank.gif) | Name | Last modified | Size | Description |
|
![[PARENTDIR]](/icons/back.gif) | Parent Directory | | - | |
![[IMG]](/icons/image2.gif) | greg-koski,alliance-for-clinical-research-excellence-and-safety,-usa-(4)-1440753969.jpg | 2017-04-18 08:12 | 3.8K | |
![[IMG]](/icons/image2.gif) | greg-koski,alliance-for-clinical-research-excellence-and-safety,-usa-1440754001.jpg | 2017-04-18 08:12 | 3.4K | |
![[IMG]](/icons/image2.gif) | greg-koski,alliance-for-clinical-research-excellence-and-safety,-usa-(3)-1440754009.jpg | 2017-04-18 08:12 | 3.7K | |
![[IMG]](/icons/image2.gif) | greg-koski,alliance-for-clinical-research-excellence-and-safety,-usa-(6)-1440754073.jpg | 2017-04-18 08:12 | 3.7K | |
![[IMG]](/icons/image2.gif) | greg-koski,alliance-for-clinical-research-excellence-and-safety,-usa-(5)-1440754090.jpg | 2017-04-18 08:12 | 3.5K | |
![[IMG]](/icons/image2.gif) | giovanni-furlan,-helsinn-birex,-ireland-1440754151.jpg | 2017-04-18 08:12 | 3.5K | |
![[IMG]](/icons/image2.gif) | giovanni-furlan,-helsinn-birex,-ireland-(2)-1440754162.jpg | 2017-04-18 08:12 | 3.4K | |
![[IMG]](/icons/image2.gif) | giovanni-furlan,-helsinn-birex,-ireland-(5)-1440754177.jpg | 2017-04-18 08:12 | 3.5K | |
![[IMG]](/icons/image2.gif) | giovanni-furlan,-helsinn-birex,-ireland-(6)-1440754185.jpg | 2017-04-18 08:12 | 3.4K | |
![[IMG]](/icons/image2.gif) | kieran-o-donnell,-tmc-pharma-services,-uk-1440754241.jpg | 2017-04-18 08:12 | 3.0K | |
![[IMG]](/icons/image2.gif) | kieran-o-donnell,-tmc-pharma-services,-uk-(2)-1440754254.jpg | 2017-04-18 08:12 | 3.2K | |
![[IMG]](/icons/image2.gif) | kieran-o-donnell,-tmc-pharma-services,-uk-(3)-1440754268.jpg | 2017-04-18 08:12 | 3.2K | |
![[IMG]](/icons/image2.gif) | angela-van-der-salm,-dada-consultancy-b-v,-netherlands-1440754294.jpg | 2017-04-18 08:12 | 3.6K | |
![[IMG]](/icons/image2.gif) | kieran-o-donnell,-tmc-pharma-services,-uk-(4)-1440754277.jpg | 2017-04-18 08:12 | 3.3K | |
![[IMG]](/icons/image2.gif) | angela-van-der-salm,-dada-consultancy-b-v,-netherlands-(2)-1440754306.jpg | 2017-04-18 08:12 | 3.6K | |
![[IMG]](/icons/image2.gif) | angela-van-der-salm,-dada-consultancy-b-v,-netherlands-(3)-1440754314.jpg | 2017-04-18 08:12 | 3.5K | |
![[IMG]](/icons/image2.gif) | angela-van-der-salm,-dada-consultancy-b-v,-netherlands-(4)-1440754321.jpg | 2017-04-18 08:12 | 3.6K | |
![[IMG]](/icons/image2.gif) | peter-lannon,-lanpharm-consulting-ta-lanpharm-services,-uk-1440754335.jpg | 2017-04-18 08:12 | 3.6K | |
![[IMG]](/icons/image2.gif) | peter-lannon,-lanpharm-consulting-ta-lanpharm-services,-uk-(2)-1440754352.jpg | 2017-04-18 08:12 | 3.6K | |
![[IMG]](/icons/image2.gif) | subodh-bhardwaj,-arable-corporation,-usa-1440754371.jpg | 2017-04-18 08:12 | 3.3K | |
![[IMG]](/icons/image2.gif) | subodh-bhardwaj,-arable-corporation,-usa-(2)-1440754378.jpg | 2017-04-18 08:12 | 3.1K | |
![[IMG]](/icons/image2.gif) | subodh-bhardwaj,-arable-corporation,-usa-(3)-1440754386.jpg | 2017-04-18 08:12 | 3.7K | |
![[IMG]](/icons/image2.gif) | pramod-wable,-daiichi-sankyo-development-ltd,-uk-1440754403.jpg | 2017-04-18 08:12 | 3.8K | |
![[IMG]](/icons/image2.gif) | subodh-bhardwaj,-arable-corporation,-usa-(4)-1440754392.jpg | 2017-04-18 08:12 | 3.7K | |
![[IMG]](/icons/image2.gif) | pramod-wable,-daiichi-sankyo-development-ltd,-uk-(2)-1440754417.jpg | 2017-04-18 08:12 | 3.0K | |
![[IMG]](/icons/image2.gif) | pramod-wable,-daiichi-sankyo-development-ltd,-uk-(3)-1440754426.jpg | 2017-04-18 08:12 | 3.3K | |
![[IMG]](/icons/image2.gif) | pramod-wable,-daiichi-sankyo-development-ltd,-uk-(4)-1440754438.jpg | 2017-04-18 08:12 | 3.3K | |
![[IMG]](/icons/image2.gif) | doaa-a-ghareeb,-alexandria-university,-egypt-(2)-1440754467.jpg | 2017-04-18 08:12 | 3.6K | |
![[IMG]](/icons/image2.gif) | doaa-a-ghareeb,-alexandria-university,-egypt-1440754454.jpg | 2017-04-18 08:12 | 3.6K | |
![[IMG]](/icons/image2.gif) | alistair-coates,-oviya-medsafe,-uk-1440754493.jpg | 2017-04-18 08:12 | 3.5K | |
![[IMG]](/icons/image2.gif) | alistair-coates,-oviya-medsafe,-uk-(2)-1440754504.jpg | 2017-04-18 08:12 | 3.5K | |
![[IMG]](/icons/image2.gif) | alistair-coates,-oviya-medsafe,-uk-(4)-1440754513.jpg | 2017-04-18 08:12 | 3.4K | |
![[IMG]](/icons/image2.gif) | alistair-coates,-oviya-medsafe,-uk-(5)-1440754520.jpg | 2017-04-18 08:12 | 3.5K | |
![[IMG]](/icons/image2.gif) | aneta-andrychowicz,-military-medical-institute,-poland-1440754575.jpg | 2017-04-18 08:12 | 3.8K | |
![[IMG]](/icons/image2.gif) | aneta-andrychowicz,-military-medical-institute,-poland-(2)-1440754584.jpg | 2017-04-18 08:12 | 3.2K | |
![[IMG]](/icons/image2.gif) | aneta-andrychowicz,-military-medical-institute,-poland-(3)-1440754589.jpg | 2017-04-18 08:12 | 3.5K | |
![[IMG]](/icons/image2.gif) | aneta-andrychowicz,-military-medical-institute,-poland-(4)-1440754595.jpg | 2017-04-18 08:12 | 3.7K | |
![[IMG]](/icons/image2.gif) | j.-pablo-salvador,--ciber-bbn,spain-1440754611.jpg | 2017-04-18 08:13 | 3.6K | |
![[IMG]](/icons/image2.gif) | j.-pablo-salvador,--ciber-bbn,spain-(3)-1440754624.jpg | 2017-04-18 08:13 | 3.5K | |
![[IMG]](/icons/image2.gif) | j.-pablo-salvador,--ciber-bbn,spain-(4)-1440754641.jpg | 2017-04-18 08:13 | 3.5K | |
![[IMG]](/icons/image2.gif) | j.-pablo-salvador,--ciber-bbn,spain-(5)-1440754649.jpg | 2017-04-18 08:13 | 3.4K | |
![[IMG]](/icons/image2.gif) | mahek,-amity-university,-india-(2)-1440754723.jpg | 2017-04-18 08:14 | 3.3K | |
![[IMG]](/icons/image2.gif) | michelle-perry,-aspen-pharmacare-trading-limited,-ireland-(5)-1440754746.jpg | 2017-04-18 08:15 | 3.6K | |
![[IMG]](/icons/image2.gif) | michelle-perry,-aspen-pharmacare-trading-limited,-ireland-(3)-1440754762.jpg | 2017-04-18 08:15 | 3.6K | |
![[IMG]](/icons/image2.gif) | 017-1440757163.jpg | 2017-04-18 08:15 | 4.1K | |
![[IMG]](/icons/image2.gif) | 019-1440757167.jpg | 2017-04-18 08:15 | 4.2K | |
|